Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
18 studies found for:    Open Studies | "Eyelid Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
Condition: Chalazion
Interventions: Drug: SUN-131 1.5% TDS;   Drug: Placebo TDS
2 Unknown  Chalazion Treatment Trial
Condition: Eyelid Chalazion
Interventions: Drug: Tobrex Drops and Ointment;   Drug: Tobradex Drops and Ointment;   Drug: Warm Compresses
3 Recruiting Chalazia Treatment Study
Condition: Chalazion
Interventions: Drug: 5-fluorouracil Injection;   Drug: Triamcinolone Acetonide;   Procedure: Incision and Curettage;   Drug: Triamcinolone Acetonide/5-fluorouracil mixture
4 Recruiting Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Procedure: Botulinum toxin A injection (5 sites: 12.5U);   Procedure: Botulinum toxin A injection (4 sites: 10U);   Drug: Botulinum toxin A 12.5U;   Drug: Botulinum toxin A 10U
5 Unknown  Comparison of Argon Laser and Radiofrequency in Trichiasis Treatment
Condition: Trichiasis
Intervention: Procedure: argon laser and radiofrequency
6 Recruiting Fluorometholone as Ancillary Therapy for TT Surgery
Conditions: Trichiasis;   Trachoma;   Bilamellar Tarsal Rotation
Interventions: Drug: Fluorometholone 0.1% ophthalmic solution;   Other: Artificial tears (Placebo)
7 Unknown  Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
Conditions: Blepharospasm;   Hemifacial Spasm
Interventions: Drug: Zinc Supplement;   Drug: Sugar pill
8 Not yet recruiting Comparative Study to Evaluate ISV-305 Compared to Vehicle in Non-Bacterial Blepharitis Subjects
Condition: Non-Bacterial Blepharitis
Interventions: Drug: ISV-305;   Other: Vehicle
9 Recruiting Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Condition: Bilateral Blepharospasm (BEB)
Interventions: Drug: IncobulinumtoxinA (Xeomin), 25 Units;   Drug: IncobotulinumtoxinA (Xeomin), 12.5 Units;   Drug: Placebo;   Drug: IncobotulinumtoxinA (Xeomin), 35 Units
10 Not yet recruiting A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention
11 Recruiting Acetyl Hexapeptide-8 for Blepharospasm
Condition: Focal Dystonia
Intervention: Drug: Topical acetyl hexapeptide-8
12 Recruiting Demodex Blepharitis Treatment Study
Condition: Chronic Blepharitis
Interventions: Drug: Terpinen-4-ol;   Other: Placebo
13 Unknown  Intralesional Tetracycline Injection in the Treatment of Chalazia
Conditions: Chalazia;   Chalazion
Intervention: Drug: Tetracycline
14 Recruiting Comparison Between Clinical Measurements and Computer-based Measurements on Digital Photographs to Evaluate Blepharoptosis
Condition: Blepharoptosis
Intervention: Other: Method comparison
15 Unknown  Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid
Condition: Blepharoptosis
Interventions: Procedure: Frontal nerve block with 2% lidocaine with 1:100,000 dilution of epinephrine;   Procedure: Subconjunctival injection of 2% lidocaine with 1:100,000 dilution with epinephrine
16 Unknown  Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage
Condition: Hordeolum
Interventions: Drug: neomycin sulfate, polymyxin B sulfate and gramicidin;   Drug: Artificial tear
17 Not yet recruiting rTMS and Botulinum Toxin in Benign Essential Blepharospasm
Condition: Benign Essential Blepharospasm
Interventions: Device: Magstim RapidStim2;   Device: Sham Magstim RapidStim2
18 Unknown  Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
Conditions: Palpebral Pathologies;   Ocular Surface Disease;   Meibomian Gland Dysfunction
Intervention:

Indicates status has not been verified in more than two years